Work

Effective Immunomodulation with Pomalidomide Beginning at Early Lymphocyte Recovery during Induction Timed Sequential Therapy (TST) for Acute Myeloid Leukemia (AML) and High-Risk Myelodysplasia (HR-MDS)

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-114961

Authors: Joshua F Zeidner, Hanna Knaus, Amer M. Zeidan, Amanda Blackford, Raul Montiel-Esparza, Gabrielle T. Prince, Lukasz P. Gondek, Gabriel Ghiaur, Margaret M. Showel, Amy E. DeZern, Keith W. Pratz, B. Douglas Smith, Mark J. Levis, Matthew C Foster, Catherine C. Coombs, Howard Streicher, Judith E. Karp, Leo Luznik, Ivana Gojo

Institutions: University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Comprehensive Cancer Center, Yale University, National Institutes of Health, National Cancer Institute

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2911255595

Cites:

Cited by:

Related to: 10